Amneal Pharmaceuticals (AMRX) Goodwill (2017 - 2026)

Amneal Pharmaceuticals' Goodwill history runs 10 years deep, the most recent figure standing at $593.8 million for Q1 2026.

• In Q1 2026, Goodwill fell 0.62% year-over-year to $593.8 million; the TTM figure through Mar 2026 stood at $593.8 million (down 0.62% YoY), while the FY2025 annual figure was $595.5 million, changed 0.33% from the prior year.
• Goodwill was $593.8 million for Q1 2026 at Amneal Pharmaceuticals, roughly flat from $595.5 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $602.9 million in Q1 2022 to a low of $593.8 million in Q1 2026.
• Historically, Goodwill has averaged $598.3 million across 5 years, with a median of $598.5 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Goodwill rose 15.33% in 2022, then dropped 0.62% in 2023.
• A 5-year view of Goodwill shows it stood at $598.9 million in 2022, then fell by 0.04% to $598.6 million in 2023, then decreased by 0.2% to $597.4 million in 2024, then dropped by 0.33% to $595.5 million in 2025, then fell by 0.28% to $593.8 million in 2026.
• The last three Goodwill figures came in at $593.8 million (Q1 2026), $595.5 million (Q4 2025), and $595.9 million (Q3 2025), per Business Quant data.